Michael Michaelides
Cellular and Molecular Neuroscience · 2017–2019
A researcher in the Science corpus: 2 papers; trusts 17 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Cellular and Molecular Neuroscience — 33 citations into it
- Cognitive Neuroscience — 20 citations into it
- Molecular Biology — 17 citations into it
- Clinical Psychology — 10 citations into it
- Epidemiology — 7 citations into it
Whom Michael Michaelides trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- Nora D. Volkow
- E. Nestler
- Barry J. Everitt
- M. Morales
- Jeremy K. Seamans
- Rita Z. Goldstein
- Nasir H. Naqvi
- John Salamone
- S. Valentine
- J. S. Fowler
Papers from Michael Michaelides's perspective
Ordered by how strongly the researchers Michael Michaelides trusts endorse each paper. Same corpus, a different order for every researcher.
- Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. (American Journal of Psychiatry)
- The hidden island of addiction: the insula (Trends in Neurosciences)
- Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex. (Cerebral Cortex)
- The mysterious motivational functions of mesolimbic dopamine. (Neuron)
- Drug Addiction: Updating Actions to Habits to Compulsions Ten Years On. (Annual Review of Psychology)
- The principal features and mechanisms of dopamine modulation in the prefrontal cortex. (Progress in neurobiology)
- Molecular Mechanisms of Opioid Receptor-Dependent Signaling and Behavior (Anesthesiology)
- Mesolimbic Dopamine Signals the Value of Work (Nature Neuroscience)
- A systematic review of social stress and mental health among transgender and gender non-conforming people in the United States (Clinical Psychology Review)
- Is there a common molecular pathway for addiction? (Nature Neuroscience)
Their papers
- The Neuroscience of Drug Reward and Addiction. (2019) — 703 citations
- Chemogenetics revealed: DREADD occupancy and activation via converted clozapine (2017) — 895 citations